Home/Filings/4/0001144204-09-012967
4//SEC Filing

GERSHICK STEVEN 4

Accession 0001144204-09-012967

CIK 0001174228other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 12:50 PM ET

Size

5.7 KB

Accession

0001144204-09-012967

Insider Transaction Report

Form 4
Period: 2009-03-06
GERSHICK STEVEN
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2009-03-06+250,000250,000 total
    Exercise: $0.45Common Stock (250,000 underlying)
Footnotes (2)
  • [F1]Option vests ratably over 36 months from date of grant 3-6-09.
  • [F2]Stock option expires on March 6, 2014, subject to automatic extension if Reporting Person is still employed by the Issuer on such date.

Documents

1 file

Issuer

NURX PHARMACEUTICALS, INC.

CIK 0001174228

Entity typeother

Related Parties

1
  • filerCIK 0001179560

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 12:50 PM ET
Size
5.7 KB